Lanean...
Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment
This Review discusses the various types of non-coding oligonucleotides, which have garnered extensive interest as new alternatives for targeted cancer therapies over small molecule inhibitors and monoclonal antibodies. These oligonucleotides can target any hallmark of cancer, no longer limited to so...
Gorde:
| Argitaratua izan da: | Cancer Treat Rev |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4826844/ https://ncbi.nlm.nih.gov/pubmed/26930249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2016.02.005 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|